Article
LNP-CpG: deploy the self-adjuvant role of mRNA vaccines
2026-08-23
Abstract excerpt
With the rapid advancement of mRNA vaccines, lipid nanoparticles (LNPs) have emerged as pivotal carriers and adjuvants for non-mRNA vaccine modalities, driven by their superior nucleic acid delivery efficiency and intrinsic self-adjuvanting properties. In this study, we systematically evaluated various formulation strategies combining LNPs and the CpG adjuvant within a varicella-zoster virus glycoprotein E (VZV-gE...
Topics
Open a Topic to create a Post that cites this publication.
- Animal Virus Infections Studies
- Antimicrobial Resistance in Staphylococcus
- Immunotherapy and Immune Responses
- Infective Endocarditis Diagnosis and Management
- RNA Interference and Gene Delivery
- SARS-CoV-2 and COVID-19 Research
- Streptococcal Infections and Treatments
- Viral gastroenteritis research and epidemiology
Identifiers and source
- Literature Corpus work
- 1f9d3f28-5ccb-5f71-877b-15011cf9ee0a
- DOI
- 10.64898/2026.08.19.745633
